ArticleJournal of clinical microbiology2004
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.
Article in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 61 citations in OpenAlex.
- Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.Clinical and vaccine immunology : CVI · 2014Trial
- Laboratory diagnosis of pertussis: A survey on provincial public health laboratory methods.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026Article
- Population dynamics and antigenic drift ofEmerging microbes & infections · 2019Article
- Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.Journal of clinical microbiology · 2017Article
- Roads to the development of improved pertussis vaccines paved by immunology.Pathogens and disease · 2015Review
- Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).PloS one · 2015Article
- Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran.International journal of molecular and cellular medicine · 2015Article
- Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.Journal of clinical microbiology · 2013Article
- Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan.PloS one · 2013Article
- Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.Clinical and vaccine immunology : CVI · 2012Article
- Population diversity among Bordetella pertussis isolates, United States, 1935-2009.Emerging infectious diseases · 2012Article
- The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.Microbiology (Reading, England) · 2012Review
- Article
- Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea.Osong public health and research perspectives · 2011Article
- Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.Journal of clinical microbiology · 2011Article
- Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.PloS one · 2011Article
- Article
- Effect of vaccination on Bordetella pertussis strains, China.Emerging infectious diseases · 2010Article
- Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.Clinical and vaccine immunology : CVI · 2010Article
- Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.BMC microbiology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fim genes which code for the fimbria protective antigens present in both the inactivated whole-cell and acellular vaccines were analyzed in 86 Canadian Bordetella pertussis isolates. At least one of the novel mutations identified was found to involve a surface epitope that has been mapped by serum antibodies from infected or vaccinated subjects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.